Search
Select region
Close filter

Moses Zonana

Contact Details

+305 569 1014

Moses Zonana draws on his experience in MedTech, digital health, telecom and technology to help clients across a range of industries tackle complex transformation, leadership, and organizational challenges. He is active in Egon Zehnder’s Healthcare and Technology Communications Practices, and he is particularly energized by building resilient, adaptable, cohesive, and purpose-driven teams.

Sustainable organizational success is about people, processes, product, and purpose. I am privileged to work with industry leaders to funnel the right talent to the right leadership roles and contextual purpose to harness the full potential of people.

Before joining the Firm, Moses was an entrepreneur, founding and running several start-ups, including Compliance Meds Technologies, Reliance Meds, TLeMAZ and NetLogistiK.

He earned an MBA from Harvard University and a BA from Rutgers University. Moses is active in Angel Investment Groups and was a member of the Entrepreneurs Organization (South Florida Chapter) for more than 10 years. Outside of work, Moses is an avid squash and tennis player.

Get in touch
Send Moses a Message
Browse all
Thought Leadership

Related Experts Around the Globe

Andreas Gavrielides

Andreas Gavrielides

Athens

Andreas Gavrielides founded Egon Zehnder’s Athens office and helped to establish the firm’s presence in Turkey and Central Europe. Read more

Kati Najipoor-Smith

Kati Najipoor-Smith

Frankfurt

Kati Najipoor-Smith, based in Frankfurt, leads Egon Zehnder’s global CEO Practice and is also deeply involved in the firm’s Board Consulting Practice. Read more

Barbara Kroll

Barbara Kroll

London

Barbara Kroll, based in London, supports clients across Europe as a member of Egon Zehnder’s Technology and Communications Practice. Read more

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top